Restylane Kysse receives positive feedback
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Global pharmaceutical company Galderma has created a new training and support programme to help customers get back on their feet once restrictions lift and clinics can open again.
Hyaluronic acid dermal filler Restylane Kysse has been approved by the US Food and Drug Administration (FDA) for lip augmentation and the correction of upper perioral rhytids.
Pharmaceutical company Galderma (UK) Limited and aesthetic and skincare product supplier Med-fx Ltd will launch new, enhanced packages of customer-centric support services for healthcare professionals who purchase products marketed under the Azzalure and Restylane brands in the UK and Ireland from September 8.
Pharmaceutical company Galderma (UK) Limited has confirmed that aesthetic and skincare product supplier Med-fx Ltd will become the company’s preferred distributor, subject to contract, for its aesthetics portfolio.
Pharmaceutical company Galderma (UK) Limited has begun a review of its distribution arrangements and announced plans to appoint one preferred distributor for its Azzalure and Restylane brands.
Pharmaceutical company Galderma will be hosting a free, two-hour webinar on the Aesthetics Media website between 7-9pm on March 11.
Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.